Securities Probe Launched Into IBM Over z17 Mainframe Claims After Q2 Miss
IBM is trading near its 52-week low of $211.03 (0.4% above the low) on elevated volume (2.9× avg).
Summary
A securities investigation has been opened into IBM over alleged misleading statements about its z17 mainframe and Z platform performance, citing CEO Arvind Krishna's claims. This follows the company's pre-announced Q2 miss on July 14, where revenue of $17.2B and adjusted EPS of $2.93 fell short of estimates, triggering a historic 25% single-day share plunge. The probe adds legal risk to an already battered stock trading near its 52-week low. With analysts skeptical about a software growth rebound, the investigation could further erode investor confidence and delay any recovery.
At the time of this announcement, IBM was trading at $211.77 on NYSE in the Technology sector, with a market capitalization of approximately $198.5B. The 52-week trading range was $211.03 to $332.46. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.